Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $1.99 billion. The enterprise value is $1.67 billion.
Important Dates
The next estimated earnings date is Tuesday, March 17, 2026, after market close.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OLMA has 78.66 million shares outstanding. The number of shares has increased by 54.75% in one year.
| Current Share Class | 78.66M |
| Shares Outstanding | 78.66M |
| Shares Change (YoY) | +54.75% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 3.07% |
| Owned by Institutions (%) | 68.72% |
| Float | 57.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.66 |
| P/TBV Ratio | 6.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.03 |
| Quick Ratio | 7.97 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.22% and return on invested capital (ROIC) is -39.11%.
| Return on Equity (ROE) | -59.22% |
| Return on Assets (ROA) | -34.41% |
| Return on Invested Capital (ROIC) | -39.11% |
| Return on Capital Employed (ROCE) | -51.60% |
| Weighted Average Cost of Capital (WACC) | 14.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 122 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +282.50% in the last 52 weeks. The beta is 1.93, so OLMA's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +282.50% |
| 50-Day Moving Average | 27.50 |
| 200-Day Moving Average | 12.01 |
| Relative Strength Index (RSI) | 46.68 |
| Average Volume (20 Days) | 1,322,515 |
Short Selling Information
The latest short interest is 9.10 million, so 11.57% of the outstanding shares have been sold short.
| Short Interest | 9.10M |
| Short Previous Month | 10.40M |
| Short % of Shares Out | 11.57% |
| Short % of Float | 15.88% |
| Short Ratio (days to cover) | 4.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -160.38M |
| Pretax Income | -149.96M |
| Net Income | -149.96M |
| EBITDA | -159.96M |
| EBIT | -160.38M |
| Earnings Per Share (EPS) | -$1.81 |
Full Income Statement Balance Sheet
The company has $328.96 million in cash and $4.48 million in debt, with a net cash position of $324.48 million or $4.13 per share.
| Cash & Cash Equivalents | 328.96M |
| Total Debt | 4.48M |
| Net Cash | 324.48M |
| Net Cash Per Share | $4.13 |
| Equity (Book Value) | 307.49M |
| Book Value Per Share | 4.48 |
| Working Capital | 292.67M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -134.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -134.67M |
| FCF Per Share | -$1.71 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OLMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.75% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.52% |
| FCF Yield | -6.75% |
Analyst Forecast
The average price target for OLMA is $41.14, which is 62.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.14 |
| Price Target Difference | 62.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -5.54% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |